Novavax (NVAX) Interest & Investment Income (2010 - 2021)
Novavax (NVAX) recorded quarterly Interest & Investment Income of $303000.0 in Q4 2021, down 8.18% quarter-over-quarter from $330000.0 in Q3 2021, and up 113.38% on a YoY basis from $142000.0 in Q4 2020.
Novavax (NVAX) Interest & Investment Income (2010 - 2021) Analysis & Trends
Novavax's Interest & Investment Income history runs 12 years deep, the most recent figure standing at $303000.0 for Q4 2021.
- In Q4 2021, Interest & Investment Income rose 113.38% year-over-year to $303000.0; the TTM figure through Dec 2021 stood at $1.4 million (up 34.38% YoY), while the FY2021 annual figure was $1.4 million, up 34.52% from the prior year.
- Interest & Investment Income was $303000.0 for Q4 2021 at Novavax, down from $330000.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $807000.0 in Q2 2018 to a low of $140000.0 in Q3 2020.
- Historically, Interest & Investment Income has averaged $425550.0 across 5 years, with a median of $419000.0 in 2017.
- The sharpest annual moves came in 2020 and 2021: Interest & Investment Income sank 59.06% in 2020, then surged 135.71% in 2021.
- A 5-year view of Interest & Investment Income shows it stood at $418000.0 in 2017, then soared by 39.71% to $584000.0 in 2018, then slumped by 52.74% to $276000.0 in 2019, then slumped by 48.55% to $142000.0 in 2020, then soared by 113.38% to $303000.0 in 2021.
- The last three Interest & Investment Income figures came in at $303000.0 (Q4 2021), $330000.0 (Q3 2021), and $369000.0 (Q2 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 597,319.59 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 305,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -14.79 Mn |
| 10 | Novavax | 1.49 Bn | 931.98 Mn | 108.82 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 303,000.00 |
| Sep 30, 2021 | 330,000.00 |
| Jun 30, 2021 | 369,000.00 |
| Mar 31, 2021 | 362,000.00 |
| Dec 31, 2020 | 142,000.00 |
| Sep 30, 2020 | 140,000.00 |
| Jun 30, 2020 | 297,000.00 |
| Mar 31, 2020 | 436,000.00 |
| Dec 31, 2019 | 276,000.00 |
| Sep 30, 2019 | 342,000.00 |
| Jun 30, 2019 | 474,000.00 |
| Mar 31, 2019 | 420,000.00 |
| Dec 31, 2018 | 584,000.00 |
| Sep 30, 2018 | 752,000.00 |
| Jun 30, 2018 | 807,000.00 |
| Mar 31, 2018 | 531,000.00 |
| Dec 31, 2017 | 418,000.00 |
| Sep 30, 2017 | 531,000.00 |
| Jun 30, 2017 | 523,000.00 |
| Mar 31, 2017 | 474,000.00 |